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coronary sinus. Table 1 summarizes the mean anatomical measurements achieved from
the major veins of 18 human hearts. The veins are labeled as follows: Posterior
Interventricular Vein (PIV), Posterior Vein (PV), Postero-Lateral Vein (PLV), Lateral
Vein (LV), Antero-Lateral Vein (ALV), and Anterior Interventricular Vein (AIV).
Standard deviation, maximum, and minimum parameters were also taken.
Table 1: Mean anatomical parameters for 18 human cardiac venous systems
Conclusion: This novel database of cardiac venous anatomical parameters will allow
one to better visualize and understand the degree of anatomical variability that exists
between human hearts. We will continue to build this data set, which should be of great
value for both device designers and those clinically implanting cardiac devices.
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TCT-621
Long-term (5 years) Serial in vivo Evaluation of Chronic Stent Recoil after
Drug-Elutig Stent Implantation: Does it exits?
Carlos Adolfo Collet, Jose R Costa, Alexandre Abizaid, Fausto Feres, Juan S Munoz,
Ricardo Costa, Daniel Chamie, Dimitry Siqueira, Amanda Sousa, Rodolfo Staico,
Jose E Sousa
Dante Pazzanese Institute Of Cardiology, Sao Paulo, Brazil
Background: Radial expansion and scaffold properties of stainless steel stents
improved acute and mid-term outcomes of coronary angioplasty. However, late stent
recoil has been proposed as one of the possible mechanisms of in-stent restenosis. We
sought to investigate the temporal course of stent expansion using serial intravascular
ultrasound (IVUS) after stainless steel drug-eluting stent (DES) implantation.
Methods: Twenty-two patients with single de novo coronary lesions were treated with
DES with stainless steel platform (10 Cypher and 12 Biomatrix) and underwent
intravascular ultrasound at post-procedure, 9-month and 5 years after implantation. We
only included patients with at least three serial IVUS acquisitions (post procedure, mid
and very long-term). The primary endpoint was the comparison of stent volume and
stent volume index between index procedure, mid and very long-term follow-up.
Results: The mean age was 59 years, with 28% of diabetes mellitus. Stable coronary
syndrome was the initial clinical indication for the majority of the cases (88%). Stent
volume and stent volume index (SVI) were not significantly different between post-
procedure and very-long term follow-up (stent volume 140.6 ± 39.1 mm3 vs. 139.9 ±
32.7 mm3, p=0.88 and SVI 7.7 ± 1.5 mm3/mm vs. 7.8 ± 1.6 mm3/mm, p=0.77). Vessel
volume index also did not significantly changed between post-procedure and long-
term follow-up (16.4 ± 4.7 mm3/mm vs. 15.1 ± 3.6 mm3/mm, p=0.28) with a low
5-year neointinal hyperplasia percent volume of obstruction (4.8%). Regarding
incomplete stent apposition (ISA), 2 cases were observed at the index procedure and
persisted until the last evaluation. There were no cases of acquired ISA.
Conclusion: The present serial IVUS assessment represents the longest serial
evaluation of late stent expansion. There was no evidence of in vivo chronic stent recoil
after stainless steel drug-eluting stent implantation.
TCT-622
The Clinical Impact of Intravascular Ultrasound in Patients Undergoing
Implantation of Drug-eluting Stents in the Left Main
Abdi Jama, Federico Conrotto, Ryan Lennon, Amir Lerman
Cardiology, Mayo Clinic, Rochester, MN
Background: The clinical utility of intravascular ultrasound during left main stenting
with drug-eluting stents (DES) has not been well understood. We sought to determine
if the use of intravascular ultrasound during left main stenting with DES in high risk
patients yields future clinical benefit in terms of survival, and reduction in recurrent
myocardial infarction (MI) and revascularization.
Methods: Medical records of 624 patients who underwent left main coronary stenting
between August 1990 and November 2010 at Mayo Clinic were reviewed. 329 patients
who had implantation of bare metal stents were excluded. 111 patients who had
intravascular ultrasound performed during DES stenting of the left main were
compared with 184 patients with conventional angiography and stenting. Of the 295
patients with implantation of DES into the left main, 100 had unprotected left main
disease. Information was collected on patient characteristics, comorbidities,
presentation, ejection fraction, recurrent MI, target lesion and target vessel
revascularization and mortality. The primary end point was mortality. Secondary end
points were revascularization and MI.
Results: The two groups were well matched for clinical and angiographic
characteristics. Patients undergoing IVUS during DES implantation were less likely
to have had coronary artery bypass surgery, underwent more direct stenting, post-
dilatation, and had shorter stent length. At three years, there was no difference in
survival between the IVUS and NO IVUS group (15.8 vs.13.3%, p=0.833). There was
no difference in revascularization (17.7 vs. 20.6%, p=0.994) between the groups. There
was a trend towards increased MI in the IVUS compared to the NO IVUS group
although not statistically significant (11.5% vs 5.3%, p=0.073). Among the 100 patients
with unprotect left main and DES stenting; there were no difference in mortality,
revascularization and MI between the groups.
Conclusion: Utilization of intravascular ultrasound during implantation of DES into
the left main might not improve long-term mortality or reduce recurrent MI and
revascularization.
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Background: The Cappella Sideguard sidebranch (SB) stent is a self-expanding, thin-
strut, nitinol device with anatomic flaring at the SB ostium.
Methods: We performed intravascular ultrasound (IVUS) post-intervention and IVUS
(n=28) and OCT (n=12) at follow-up and compared serial changes between the
Cappella Sideguard stent in the SB and a balloon-expandable drug-eluting stent (DES)
in the corresponding main vessel (MV).
Results: 1. Cappella Sideguard stent carinal area increased from 3.9±1.3mm2 post-
intervention to 4.6±1.3mm2 at follow-up (p<0.001) that led no change in lumen area
(3.9±1.3 to 3.8±1.2mm2, p=0.7) despite a neointimal hyperplasia (NIH) area of
0.8±0.8mm2. 2. Compared to the MV, in the SB there was a larger NIH volume and a
significant increase in stent (4.9±3.6 vs 0.3±3.0mm3, p<0.001) and vessel volumes,
with no difference in Δlumen volume. 3. NIH peaked 1-2mm distal to the carina
(Figure). 4. Using OCTNIH thickness at the SB side of the bifurcation was greater
than at the MV side, the percentage of uncovered struts was less (2.9% at SB vs 12.7%
at MV, p<0.001), and 61% of floating stent struts at the carina were covered by smooth
tissue.
Conclusion: The self-expanding Cappella Sideguard stent maintains an adequate
lumen, especially at the SB carina at follow-up, with NIH accumulation mainly 1~2mm
distal to the carina that correlates to the increase in stent dimensions.
TCT-624
Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting
Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in
One Procedure. A 12 Months Follow Up Evaluation
Jose M De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad
Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco
Hemodinamica, Hospital U. Marques de Valdecilla, Santander, Spain
Background: Optical frequency-domain imaging (OFDI) allows a detailed assessment
of intimal coverage and strut apposition which are factors well known associated with
late thrombosis. This study seeks to asses and compare long term intimal coverage and
stent apposition with paclitaxel-eluting stents (PES) Taxus Liberte TM and everolimus-
eluting stents (EES) Xience Prime TM.
Methods: We have applied a particular clinical model, that of a same patient with two
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